ACROBiosystems/Human FcRn / FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (SPR & BLI verified)/1mg (500ug × 2)/FCM

价格
¥48000.00
货号:FCM
浏览量:127
品牌:ACROBiosystems
服务
全国联保
正品保证
正规发票
签订合同
商品描述
  • Synonym
    FcRn,FCGRT & B2M
  • Source
    Human FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (SPR& BLI verified) (FCM-H5286) is expressed from human 293 cells (HEK293). It contains AA Ala 24 - Ser 297 (FCGRT) & Ile 21 - Met 119 (B2M) (Accession # P55899-1(FCGRT) & P61769-1(B2M)).
    Predicted N-terminus: Ala 24 (FCGRT) & Ile 21 (B2M)
    Request for sequence
  • Molecular Characterization
    Online(Ala 24 - Ser 297 (FCGRT) & Ile 21 - Met 119 (B2M)) P55899-1 (FCGRT) & P61769-1 (B2M)

    Human FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (SPR& BLI verified), produced by co-expression of FCGRT and B2M, has a calculated MW of 31.2 kDa (FCGRT) and 13.1 kDa (B2M). Subunit FCGRT is fused with a polyhistidine tag at the C-terminus and subunit Beta-2 microglobulin (B2M) is fused with Strep II-tag at the C-terminus. The reducing (R) protein migrates as 33 kDa (FCGRT) and 13 kDa (B2M) respectively due to glycosylation.

  • Endotoxin
    Less than 1.0 EU per μg by the LAL method.
  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;

    2. -70°C for 3 months under sterile conditions after reconstitution.

SDS-PAGE
Human FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (SPR& BLI verified) (Cat. No. FCM-H5286) SDS-PAGE gel

Human FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (SPR& BLI verified) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.

Request for HPLC data
Bioactivity-SPR
Human_FcRn_Heterodimer_Protein_SPR

Immobilized Human FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (SPR& BLI verified) (Cat. No. FCM-H5286) on CM5 Chip via Anti-His antibody, can bind Herceptin with an affinity constant of 0.261 μM as determined in a SPR assay (Biacore T200) (QC tested).

Protocol
Human_FcRn_Heterodimer_Protein_SPR
Report
Human_FcRn_Heterodimer_Protein_SPR

Immobilized Human FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (SPR& BLI verified) (Cat. No. FCM-H5286) on CM5 Chip, can bind Herceptin with an affinity constant of 1.19 μM as determined in a SPR assay (Biacore T200) (Routinely tested).

Protocol
Bioactivity-BLI
Human_FcRn_Heterodimer_Protein_Bli

Loaded Human FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (SPR& BLI verified) (Cat. No. FCM-H5286) on SA Biosensor via Biotin his antibody, can bind Herceptin with an affinity constant of 0.27 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol
Human_FcRn_Heterodimer_Protein_Bli

Loaded Human FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (SPR & BLI verified) (Cat. No. FCM-H5286) on AR2G Biosensor, can bind Herceptin with an affinity constant of 0.35 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol
Human_FcRn_Heterodimer_Protein_Bli

Loaded Biotinylated Human Serum Albumin, His,Avitag (Cat. No. HSA-H82E3) on SA Biosensor, can bind Human FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (SPR & BLI verified) (Cat. No. FCM-H5286) with an affinity constant of 0.641 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol
  • Citations
    • Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention

      Authors: Kielau Kisalu, Neville et al.

      Journal: JCI Insight 2020

      Application: BLI

      Request for Full-text

    • Engineered antibody Fc variants for enhanced serum half life

      Authors: G Georgiou, et al

      Journal: US20190048078A1 2019

      Application: SPR

      Request for Full-text

    • Control of therapeutic IgG antibodies galactosylation during cultivation process and its impact on IgG1/FcγR interaction and ADCC activity

      Authors: Simonov V, et al

      Journal: Biologicals 2019

      Application: BLI

      Request for Full-text

    • Comparative studies of the serum half-life extension of a protein via site-specific conjugation to a species-matched or -mismatched albumin.

      Authors: Yang B, et al.

      Journal: Biomater Sci 2018

      Application: ELISA

      Request for Full-text

    • Unidirectional transport of IgG by neonatal Fc receptor in human thyrocytes varies across different IgG subclasses

      Authors: Zhao C, et al.

      Journal: Mol Cell Endocrinol 2018

      Application: SPR

      Request for Full-text

    • Structural basis for pH-insensitive inhibition of immunoglobulin G recycling by an anti-neonatal Fc receptor antibody

      Authors: Kenniston JA, et al.

      Journal: J Biol Chem 2017

      Application: ELISA & SPR

      Request for Full-text

  • Background
    FCGRT & B2M heterodimer protein (FcRn complex) consist of two subunits: p51 (equivalent to FCGRT), and p14 (equivalent to beta-2-microglobulin), and forms an MHC class I-like heterodimer. Fc fragment of IgG, receptor, transporter, alpha (FCGRT) binds to the Fc region of monomeric immunoglobulins gamma and mediates the uptake of IgG from milk. FCGRT possible role in transfer of immunoglobulin G from mother to fetus. Beta-2-microglobulin (B2M) is a component of the class I major histocompatibility complex (MHC) and involved in the presentation of peptide antigens to the immune system.
  • References
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

ACROBiosystems治疗性抗体的功效不仅取决于Fab片段及其与靶抗原的结合活性,还取决于Fc片段及其与关键Fc受体的相互作用。Fc片段对FcRn的结合亲和力(FCGRT&B2M)将预测抗体的半衰期,而Fc片段与FcγRIIIa(CD16a)之间的结合亲和力将影响抗体引发ADCC的能力(抗体依赖性细胞介导的细胞毒性)。因此,必须在抗体工程化过程中针对一组受体测试候选人。ACROBiosystems提供了完整的重组Fc受体蛋白集合,包括它们的常见变体,以帮助您加快mAb的开发。